April 2022 - Page 24 of 28

WednesdayApr 06, 2022 1:04 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures Approval from France EC and ANSM Competent Authority for Potentially Pivotal Study of Berubicin

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system (“CNS”), today announced its receipt of approval from the National Agency for the Safety of Medicine and Health Products (“ANSM”) Competent Authority and from the People Protection Ethics Committee (“EC”) SUD-EST III (“CPP Sud-Est III”) in France for the company's potentially pivotal study of Berubicin for the treatment of recurrent glioblastoma multiforme (“GBM”), one of the most aggressive types of brain cancer. “Access to patients is the lifeblood of any clinical study and this…

WednesdayApr 06, 2022 12:55 pm

QualityStocksNewsBreaks – Save Foods Inc. (NASDAQ: SVFD) (FSE: 80W) Releases Letter to Stockholders

Save Foods (NASDAQ: SVFD) (FSE: 80W), an agri-food tech company specializing in eco crop protection that helps reduce food waste and ensure food safety, published a letter to its stockholders from CEO David Palach. “We achieved multiple significant milestones in 2021, successfully transitioning Save Foods from a research and development focused organization to a commercial enterprise, fueled by the transformational May 2021 listing of our common stock on the Nasdaq Capital Market through an initial public offering that raised gross proceeds of $12 million. Even though we were an R&D focused company for much of 2021, and despite ongoing travel…

WednesdayApr 06, 2022 12:39 pm

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) to Participate in Upcoming Benzinga Psychedelics Capital Conference

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), will be represented at the Benzinga Psychedelics Capital Conference. The premier event is scheduled for April 19, 2022, and will be held in Miami Beach, Florida. Cybin CEO Doug Drysdale will present a fireside chat and will also be a member of a panel discussion. Drysdale’s chat is slated to start at 1:10 p.m. ET. The panel discussion, which is titled “Short, Medium, and Long Term Catalysts in Psychedelics,” is scheduled for 3:10 p.m. ET. Archives versions of both events will be available on the company’s…

WednesdayApr 06, 2022 12:01 pm

QualityStocksNewsBreaks – GreenBox POS (NASDAQ: GBOX) Finalized ‘Momentous’ Transact Europe Acquisition

GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, has completed its acquisition of Transact Europe Holdings (“TEU”). According to the company, the $28 million purchase price was substantiated by the value of Transact Europe’s business volume, strategic licenses, systems and personnel. An EU-regulated electronic money institution, TEU is headquartered in Sofia, Bulgaria, and holds an array of valuable licenses, including principal level membership of Visa, worldwide membership of MasterCard and principal membership of China UnionPay. “This acquisition is a momentous triumph for us, representing the most significant asset to date for GreenBox, allowing us to propel forward as a…

WednesdayApr 06, 2022 9:15 am

Paris NFT and Blockchain Week Summit to Witness A New Era of Digital Assets Finance

Entrepreneurs, businesses, and enthusiasts of the modern finance, fintech, and digital assets niche are invited to attend the Paris Blockchain Week Summit being held at none other than the iconic Palais Brongniart. As an extension of the event, the PBWS will include the Paris NFT day on 12 April, to educate and spread awareness about NFT trading. Paris NFT Day Join in for an interactive session on NFTs and Web 3 ecosystem at the Paris NFT Day on 12 April. The conferences will offer a clear understanding of the projects and businesses that are underway in this niche and the key…

WednesdayApr 06, 2022 9:15 am

The Plant Medicine Week Being Held At A Heritage Venue In Malta Hosting Industry Leading Professionals

The Microdose Plant Medicine Week will be held on April 5-8th 2022, at the Mediterranean Conference Centre, one of the finest heritage buildings of Valletta, Malta. The Centre is a landmark venue having membership of the prestigious Historic Conference Centres of Europe (“HCCE”). Investors, entrepreneurs, psychedelic and cannabis researchers, policymakers, and professionals from the health, legislation, and education fields are invited to attend the event. The agenda of the event focuses on the expansion of cannabis and psychedelic medicine usage and trade on the island and reviewing the existing laws and schemes to encourage cannabis investment opportunities in Malta. Knowledge…

WednesdayApr 06, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Exploring Multiple Strong Market Paths

Lexaria is a global innovator that has developed the patented DehydraTECH(TM) technology that improves bioavailability, speed of onset, and brain absorption of active pharmaceutical ingredients (“APIs”) The company strategically partners with third-party organizations seeking to explore formulation opportunities with their specific APIs Lexaria is evaluating the effectiveness of various DehydraTECH-processed APIs, including CBD, nicotine, sildenafil, and more According to company CEO Chris Bunka, the management team is positioning the company to ensure that it has multiple paths to success In pursuit of multiple paths to success, Lexaria Bioscience (NASDAQ: LEXX), developer of the patented DehydraTECH(TM) drug delivery platform, strategically partners…

WednesdayApr 06, 2022 9:00 am

Cepton, Inc. (NASDAQ: CPTN) Poised to Benefit as Non-Automotive Sector Becomes Increasingly Important for LiDAR Producers

LiDARs have been one of key enablers for autonomous vehicle sector, but this unique technology offers use cases beyond automotive industry Consumer Electronics Show, one of the world’s most influential tech events, demonstrates that LiDAR is growing within non-automotive landscape, including smart city/infrastructure and security Cepton set to benefit as the Company has already established its presence in non-automotive, delivering LiDAR systems for smart cities, spaces, and industrial applications around the globe Cepton (NASDAQ: CPTN), a Silicon Valley leader in innovative, high-performance LiDAR solutions, appears well-positioned to benefit as the non-automotive applications of the LiDAR technology grow. LiDAR technology seems…

WednesdayApr 06, 2022 9:00 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Increasing Rare Cannabidiol Product Portfolio, Revenues

InMed Pharmaceuticals is a Canadian clinical-stage drug development company focused on the development of rare cannabinoids and their synthetic counterpoints for B2B sales and pharmaceutical potential InMed expects to have rare cannabinoids CBDV and THCV available for B2B sale to the health and wellness market in the coming months, following on the heels of its CBC and CBT products The company recently reported its first revenues from CBC sales in the wake of its acquisition of rare cannabinoids manufacturer BayMedica late last year The company is also working to develop synthetic CBN cannabinoids as potential medical treatments for select conditions,…

TuesdayApr 05, 2022 3:47 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Q4 and Fiscal Year 2021 Results, Provides Business Update

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries, today announced financial results for the fourth quarter and fiscal year ended Dec. 31, 2021. The company also provided a business update and offered guidance on its strategic changes and growth acceleration planned for FY 2022. “The PCT and BaroFold technologies have provided important early opportunities for commercial traction, as PBI forged scientific understanding and acceptance for its high-pressure platforms,” Jeffrey N. Peterson, chairman of the PBI board, said in the press release. “Building…

Site Search

Company Search

Month: April 2022

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures Approval from France EC and ANSM Competent Authority for Potentially Pivotal Study of Berubicin

QualityStocksNewsBreaks – Save Foods Inc. (NASDAQ: SVFD) (FSE: 80W) Releases Letter to Stockholders

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) to Participate in Upcoming Benzinga Psychedelics Capital Conference

QualityStocksNewsBreaks – GreenBox POS (NASDAQ: GBOX) Finalized ‘Momentous’ Transact Europe Acquisition

Paris NFT and Blockchain Week Summit to Witness A New Era of Digital Assets Finance

The Plant Medicine Week Being Held At A Heritage Venue In Malta Hosting Industry Leading Professionals

Lexaria Bioscience Corp. (NASDAQ: LEXX) Exploring Multiple Strong Market Paths

Cepton, Inc. (NASDAQ: CPTN) Poised to Benefit as Non-Automotive Sector Becomes Increasingly Important for LiDAR Producers

InMed Pharmaceuticals Inc. (NASDAQ: INM) Increasing Rare Cannabidiol Product Portfolio, Revenues

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Q4 and Fiscal Year 2021 Results, Provides Business Update

Market Basics

Newsletter Publishers

Public Companies